Non-surgical contraception in female dogs and cats

• Autorzy: Max A. , Jurka P. , Dobrzynski A. , Rijsselaere T.

Warianty tytułu

PL

Niechirurgiczne metody antykoncepcji u samic psów i kotów

• Języki publikacji: EN

Abstrakty

EN

PL

• Wydawca: -
• Czasopismo: Acta Scientiarum Polonorum. Zootechnica
• Rocznik: 2014
• Tom: 13
• Numer: 1
• Opis fizyczny: p.3-18,ref.

Twórcy

autor

Max A.

• Department of Small Animal Diseases with Clinic, Warsaw University of Life Sciences, Nowoursynowska 159, 02-776 Warsaw, Poland

autor

Jurka P.

• Warsaw University of Life Sciences, Warsaw, Poland

autor

Dobrzynski A.

• Warsaw University of Life Sciences, Warsaw, Poland

autor

Rijsselaere T.

• Ghent University, Merelbeke, Belgium

Bibliografia

• Bender S.C., Bergman D.L., Wenning K.M., Miller L.A. Slate D., Jackson F.R., Rupprecht C.E., 2009. No adverse effects of simultaneous vaccination with the immunocontra- ceptive GonaCon and a commercial rabies vaccine on rabies virus neutralizing antibody production in dogs. Vaccine 27, 7210-7213.
• Berky von A.G., Townsend W.L., 1993. The relationship between the prevalence of uterine lesions and the use of medroxyprogesterone acetate for canine population control Austr. Vet. J. 70, 249-250.
• Bertchold M., Gynäkologie, in: Freudiger U., Grunbaum E.G., Schimke E., 1986. Klinik der Hundekrankheiten, Gustav Fischer Verlag, Band 2, Jena, 643-688.
• Cathey M., Memon M.A., 2010. Nonsurgical methods of contraception in dogs and cats: Where are we now? Vet. Med. 105, 12-17.
• Colon J., Kimball M., Hansen B., Concannon P.W., 1993. Effects of contraceptive doses of the gestagen megestrol acetate on luteinizing hormone and follicle-stimulating hormone secretion in female dogs. J. Reprod. Fertil. Suppl. 47, 519-521.
• Conneely M.O., Mulac-Jericevic B., Lydon PJ., 2003. Progesterone-dependent regulation of female reproductive activity by two distinct progesterone receptor isoforms. Steroids 68, 771-778.
• De Cock H., Ducatelle R., Tilmant K., De Schepper J., 2002. Possible role for insulinlike growth factor-I in the pathogenesis of cystic endometrial hyperplasia pyometra complex in the bitch. Theriogenology 57, 2271-2287.
• Eade J.A., Robertson I.D., James C.M., 2009. Contraceptive potential of porcine and feline zona pellucida A, B and C subunits in domestic cats. Reproduction 137,913-922.
• El Etreby M.F., 1979. Effect of cyproterone acetate, levonorgestrel and progesterone on adrenal glands and reproductive organs in the beagle bitch. Cell Tissue Res. 200, 229-243.
• Evans J.M., Sutton J.D., 1989. The use of hormones, especially gestagens, to control oestrus in bitches. J. Reprod. Fertil. Supp. 39, 163-173.
• Fagerstone K.A., Miller L.A., Killian G., Yoder C.A., 2010. Review of issues concerning the use of reproductive inhibitors, with particular emphasis on resolving human- wildlife conflicts in North America. Integrative Zoology 5, 15-30.
• Fieni F., Bruyas J.F., Battut I., Tainturier D., 2001. Clinical use of anti-progestins in the bitch. Rec. Adv. Small Anim. Reprod. IVIS, Ithaca, New York USA.
• Fieni F., Martal J., Marnet P.G., Siliart B., Guittot F., 2006. Clinical, biological and hormonal study of mid-pregnancy termination in cats with aglepristone. Theriogenology 66, 1721-1728.
• Fontaine E., Fontbonne A., 2011. Clinical use of GnRH agonists in canine and feline species. Reprod. Domest. Anim. 46, 344-353.
• Gobello C., 2012. Effects of GnRH antagonists vs. agonists in domestic carnivores, a review. Reprod. Domest. Anim. 47, 373-376.
• Gorman S.P., Levy J.K., Hampton A.L., Collante W.R., Harris A.L., Brown R.G., 2002. Evaluation of a porcine zona pellucida vaccine for the immunocontraception of domestic kittens (Felis catus). Theriogenology 58, 135-149.
• Hoyer P.B., Devine P., Hu X., Thompson K.E., Sipes I.G., 2001. Ovarian toxicity of 4- -vinylcyclohexene diepoxide: A mechanistic model. Toxicol. Pathol. 29, 91-99.
• Jurka P., Kacprzak K., 2013. Elimination of “flare effect” after the use of deslorelin implant in proestrous queen. Reprod. Domest. Anim. 48, 95.
• Jurka P., Max A., 2006. Mechanizm działania oraz zastosowanie kliniczne gestagenów w rozrodzie psów i kotów [Mechanisms of clinical use of gestagens and their influence on canine and feline reproduction]. Med. Weter. 62, 130-134 [in Polish].
• Jurka P., Max A., 2009. Treatment of fibroadenomatosis in 14 cats with aglepristone. Vet. Rec. 28, 657-660.
• Keskin A., Yilmazbas G., Yilmaz R., Ozyigit M.O., Gumen A., 2009. Pathological abnormalities after long-term administration of medroxyprogesterone acetate in a queen. J. Feline Med. Surg. 11, 518-521.
• Kim K.S., Kim O., 2005. Cystic endometrial hyperplasia and endometritis in a dog following prolonged treatment of medroxyprogesterone acetate. J. Vet. Sci. 6, 81-82.
• Kutzler M., Wood A., 2006. Non-surgical methods of contraception and sterilization. Theriogenology 66, 514-525.
• Levy J.K., Friary J.A., Miller L.A., Tucker S.J., Fagerstone K.A., 2011. Long-term fertility control in female cats with GonaCon™, a GnRH immunocontraceptive. Therioge- nology 76, 1517-1525.
• Levy J.K., Mansour M., Crawford P.C., Pohajdak B., Brown R.G., 2005. Survey of zona pellucida antigens for immunocontraception of cats. Theriogenology 63, 1334-1341.
• Max A., Jurka P., 2006 a. Skutki uboczne stosowania gestagenów u psów i kotów [Adverse effects after administration of gestagens in dogs and cats]. Med. Weter. 62, 508-511 [in Polish].
• Max A., Jurka P., 2006 b. Zastosowanie antygestagenu aglepriston (Alizine, Virbac) do wywołania poronienia u suk [Induction of the abortion in bitches with aglepristone (Alizine, Virbac), progesterone antagonist]. Życie Weter. 81, 196-197 [in Polish].
• Mol J.A., van Garden E., Rytteman G.R., 1996. New insights in the molecular mechanism of progestin-induced proliferation of mammary epithelium: induction of the local biosynthesis of growth hormone (GH) in the mammary glands of dogs, cats and humans. J. Steroid Bioch. Mol. Biol. 57, 67-71.
• Mulac-Jericevic B., Conneely O.M., 2004. Reproductive tissue selective actions of progesterone receptors. Reproduction 128, 139-146.
• Munks M.W., 2012. Progress in development of immunocontraceptive vaccines for permanent non-surgical sterilization of cats and dogs. Reprod. Dom. Anim. 47, 223-227.
• Reichler I.M., 2009. Gonadectomy in cats and dogs: a review of risks and benefits. Reprod. Domest. Anim. Suppl. 2, 44, 29-35.
• Risso A., Corrada Y., Barbeito C., Diaz J.D., Gobello C., 2012. Long-term-release GnRH agonists postpone puberty in domestic cats. Reprod. Domest. Anim. 47, 936-938.
• Robbins S.C., Jeliński M.D., Stotish R.L., 2004. Assessment of the immunological and biological efficacy of two different doses of a recombinant GnRH vaccine in domestic male and female cats (Felis catus). J. Reprod. Immunol. 64, 107-119.
• Romagnoli S., Concannon P.W., 2003. Clinical use of progestins in bitches and queens: a review. Rec. Adv. Small Anim. Reprod. International Veterinary Information Service (www.ivis.org), Ithaca, New York, USA. A, 1206, 0903.
• Root Kustritz M.V., 2007. Determining the optimal age for gonadectomy of dogs and cats. J. Am. Vet. Med. Assoc. 231, 1665-1675.
• Root Kustritz M.V., 2012. Efects of surgical sterilization on canine and feline health and on society. Reprod. Domest. Anim. 47, 214-222.
• Samoylov A., Cox N., Cochran A., Wolfe K., Donovan C., Kutzler M., Petrenko V., Baker H., Samoylova T., 2012. Generation and characterization of phage-GnRH chemical conjugates for potential use in cat and dog immunocontraception. Reprod. Domest. Anim. Suppl 6, 47, 406-411.
• Saxena A., Perkins S., 2002. Modulation of ovarian function in female dogs immunized with bovine luteinizing hormone receptor. Reprod. Domest. Anim. 37, 9-17.
• Saxena B.B., Clavio A., Singh M., Rathnam P., Bukharovich E.Y., Reimers T.J. Jr, Saxena A., Perkins S., 2003. Effect of immunization with bovine luteinizing hormone receptor on ovarian function in cats. Am. J. Vet. Res. 64, 292-298.
• Springer L.N., McAsey M.E., Flaws J.A., Tilly J.L., Sipes I.G., Hoyer P.B., 1996. Involvement of apoptosis in 4-vinylcyclohexene diepoxide-induced ovotoxicity in rats. Toxicol. Appl. Pharmacol. 139, 394-401.
• Srivastava N., Santhanam R., Sheela P., Mukund S., Thakral S.S., Malik B.S., Gupta SK., 2002. Evaluation of the immunocontraceptive potential of Escherichia coli-expressed recombinant dog ZP2 and ZP3 in a homologous animal model. Reproduction 123, 847-857.
• Toydemir T.S.F., Kilicarslan M.R., Olgac V., 2012. Effects of GnRH analogue deslorelin implants on reproduction in female domestic cats. Theriogenology 77, 662-674.